荃信生物-B(02509)11月25日斥资47.27万港元回购2.32万股
Qyuns TherapeuticsQyuns Therapeutics(HK:02509) 智通财经网·2025-11-25 12:03

Core Viewpoint - The company, Zhenxin Biotechnology-B (02509), announced a share buyback plan, indicating a strategic move to enhance shareholder value through the repurchase of shares [1] Group 1 - The company will spend HKD 472,700 to repurchase 23,200 shares [1]

荃信生物-B(02509)11月25日斥资47.27万港元回购2.32万股 - Reportify